Edwards Lifesciences is a global leader in structural heart innovation and cardiovascular medical devices. The company specializes in advanced solutions such as Transcatheter Aortic Heart Valve Replacement (TAVR), which enables heart valve replacement without open-heart surgery.
Its technical domains include artificial heart valves, hemodynamic monitoring, and transcatheter heart valve replacement. These areas involve precise engineering and data-intensive monitoring systems, relevant to fields where technology and innovation intersect with healthcare.
Serving millions of patients in over 100 countries, Edwards Lifesciences operates with a culture of patient-focused innovation, emphasizing imagination, courage, and resourcefulness in improving lives through medical technology.
